Clearside Biomedical, Inc. (CLSDQ)
OTCMKTS · Delayed Price · Currency is USD
0.3700
+0.0600 (19.35%)
At close: Apr 27, 2026
Clearside Biomedical Revenue
Clearside Biomedical had revenue of $201.00K in the quarter ending September 30, 2025, a decrease of -80.64%. This brings the company's revenue in the last twelve months to $3.33M, down -56.78% year-over-year. In the year 2024, Clearside Biomedical had annual revenue of $1.66M, down -79.77%.
Revenue (ttm)
3.33M
Revenue Growth
-56.78%
P/S Ratio
0.58
Revenue / Employee
104.03K
Employees
32
Market Cap
1.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.66M | -6.56M | -79.77% |
| Dec 31, 2023 | 8.23M | 6.90M | 519.89% |
| Dec 31, 2022 | 1.33M | -28.25M | -95.51% |
| Dec 31, 2021 | 29.58M | 21.68M | 274.65% |
| Dec 31, 2020 | 7.89M | 5.72M | 263.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionClearside Biomedical News
- 5 months ago - Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process - GlobeNewsWire
- 8 months ago - Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress - GlobeNewsWire
- 9 months ago - Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada - GlobeNewsWire
- 10 months ago - Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline - GlobeNewsWire
- 11 months ago - Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting - GlobeNewsWire
- 1 year ago - Clearside Biomedical Transcript: Stifel 2025 Virtual Ophthalmology Forum - Transcripts
- 1 year ago - Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum - GlobeNewsWire
- 1 year ago - Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire